Study Stopped
Organisation problem
Limitation of the Ventilatory Response to Exercise in the Master Athlete
LAHMESS
1 other identifier
interventional
3
1 country
1
Brief Summary
It is generally accepted that the ventilatory system is not a limiting factor in physical exercise in terms of performance or exercise tolerance in healthy subjects. The ventilatory system would be oversized in relation to the stresses it has to cope with, even during maximum intensity exercise. However, some highly trained endurance athletes may be exceptions to this rule. A limitation of the expiratory flow is indeed sometimes found in these athletes, whose maximum values of ventilation can confront the mechanical limits of their ventilatory system. This phenomenon could be accentuated in elderly athletes (known as "master athletes") under the effect of structural and functional pulmonary alterations that accompany aging. Our hypothesis : What is the prevalence of exercise expiratory flow limitation in the master athlete and does it cause a decrease in physical performance via an acceleration of locomotor muscle fatigue?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy-volunteers
Started Apr 2022
Typical duration for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2022
CompletedFirst Posted
Study publicly available on registry
April 1, 2022
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedSeptember 8, 2023
September 1, 2023
1 year
March 8, 2022
September 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline severity of EFL during ergocycle endurance exercise
Force developed by the quadriceps muscle in response to percutaneous electrical stimulation of the femoral nerve
At inclusion and 3 months
Secondary Outcomes (1)
Muscle activation level
At inclusion and 3 months
Study Arms (1)
Healthy volunteers
OTHERFollowing the selection visit (#V0) to verify the inclusion and non-inclusion criteria, participants will make 2 visits (#V1 and #V2) including in particular a Respiratory Functional Exploration (EFR) and a triangular
Interventions
Participants will then complete 1 FAM (#V3) to Neuromuscular Function Assessment (PRE-POST), Pre- and Post- Exercise Ventilatory Function Assessment, and a Constant Load Ergocycle Test to Tolerance Limit (intensity fixed at 90% of the maximum aerobic power, PMA). The following two experimental visits (#V4 and #V5) will replicate the tests described in #V3. However, during the constant load exercise, participants will breathe either ambient air or heliox (a mixture in which the nitrogen in the air is replaced by the inert gas helium) in a random order. During a final Experiential Visit (#V6), participants will replicate the "Medical Gas Administration" visit but the exercise will be interrupted when a similar amount of time/work as the ambient air condition is achieved.
Following the selection visit (#V0) to verify the inclusion and non-inclusion criteria, participants will make 2 visits (#V1 and #V2) including in particular a Respiratory Functional Exploration (EFR) and a triangular VO2 MAX estimation test in Ambient Air or Heliox conditions (depending on randomization).
Eligibility Criteria
You may qualify if:
- Non-smoker (active or passive) or ex-smoker of less than 5 pack-years and stopped for more than 10 years.
- No known significant chronic pathology.
- No symptoms suggesting a progressive pathology.
- No contraindication to physical exercise. Normal Pulmonary Functional Test (PFT).
- Participants affiliated to the social security system
You may not qualify if:
- Vulnerable persons as defined in Articles L. 1121-5 to L.1121-8 and L.1122-1-2 of the Public Health Code (e.g. persons deprived of liberty, minors, adults protected, etc.),
- Participants with a medical contraindication to sports practice,
- Cardiovascular, respiratory, neuromuscular and/or significant metabolic,
- Participants with declared pathology or medical treatment,
- Smoking or drug use,
- Significant chronic drug treatment,
- Lack of consent.
- Refusal to cooperate
- Recent rhino-bronchial infection (within last 4 weeks)
- Mental disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice
Nice, Alpes-maritimes, 06001, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leroy Sylvie
Pneumologie, CHU de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2022
First Posted
April 1, 2022
Study Start
April 1, 2022
Primary Completion
April 1, 2023
Study Completion
July 1, 2023
Last Updated
September 8, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share